Literature DB >> 21771652

Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III.

G Odonne1, G Herbette, V Eparvier, G Bourdy, R Rojas, M Sauvain, D Stien.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The study of traditional remedies used by the Chayahuita, an ethnic group from the Peruvian Amazonia, has prompted us to investigate in detail the ethanolic extract of Pseudelephantopus spicatus (Juss. ex Aubl.) C.F. Baker, which has demonstrated strong biological activity towards Leishmania amazonensis. Our goal was to discover the active compound of this plant-based remedy.
MATERIALS AND METHODS: A bioguided fractionation of the crude extract was undertaken based on the biological activity recorded against Leishmania amazonensis axenic amastigotes in in vitro bioassays.
RESULTS: Three strongly to moderately active compounds were isolated: two hirsutinolides (the 8,13-diacetyl-piptocarphol and the 8-acetyl-13-O-ethyl-piptocarphol) and ursolic acid. IC(50) against Leishmania amazonensis axenic amastigotes are respectively 0.2, 0.37 and 0.99 μM (while IC(50) of amphotericin B is 0.41 μM). These compounds have never been isolated from this plant species, and germacranolides have never been identified as potential antileishmanial agents.
CONCLUSIONS: The compounds isolated from Pseudelephantopus spicatus account for the antileishmanial activity of the plant, thus giving support to its use by the Chayahuita in Peru.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771652     DOI: 10.1016/j.jep.2011.07.008

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  Cytotoxicity potentials of eleven Bangladeshi medicinal plants.

Authors:  Amina Khatun; Mahmudur Rahman; Tania Haque; Md Mahfizur Rahman; Mahfuja Akter; Subarna Akter; Afrin Jhumur
Journal:  ScientificWorldJournal       Date:  2014-11-09

3.  Simultaneous HPTLC analysis and in vitro antileishmanic activity of various secondary metabolites in extract of the traditional medicinal herb Artabotrys hexapetalus (L.f.).

Authors:  Sakshi Bajaj; Sharad Ramesh Wakode; Washim Khan; Satish Manchanda; Sachin Kumar
Journal:  Ayu       Date:  2018 Apr-Jun

Review 4.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

Review 5.  The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade.

Authors:  Patrick O Sakyi; Richard K Amewu; Robert N O A Devine; Emahi Ismaila; Whelton A Miller; Samuel K Kwofie
Journal:  Nat Prod Bioprospect       Date:  2021-07-14

6.  Natural terpenoids from Ambrosia species are active in vitro and in vivo against human pathogenic trypanosomatids.

Authors:  Valeria P Sülsen; Silvia I Cazorla; Fernanda M Frank; Laura C Laurella; Liliana V Muschietti; Cesar A Catalán; Virginia S Martino; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

7.  Three new trixane glycosides obtained from the leaves of Jungia sellowii Less. using centrifugal partition chromatography.

Authors:  Luíse Azevedo; Larissa Faqueti; Marina Kritsanida; Antonia Efstathiou; Despina Smirlis; Gilberto C Franchi; Grégory Genta-Jouve; Sylvie Michel; Louis P Sandjo; Raphaël Grougnet; Maique Weber Biavatti
Journal:  Beilstein J Org Chem       Date:  2016-04-12       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.